Journal of Urology

Oncology & Cancer

Study examines prostate cancer treatment decisions

A five-year follow-up study of more than 2,000 U.S. men who received prostate cancer treatment is creating a road map for future patients regarding long-term bowel, bladder and sexual function in order to clarify expectations ...

Oncology & Cancer

Most men do not regret their choices for prostate cancer surgery

Men with localized prostate cancer are faced with deciding among a range of options for treatment—including a choice between robot-assisted versus conventional prostatectomy. A new follow-up study in The Journal of Urology ...

Oncology & Cancer

High doses of saw palmetto don't impact serum PSA

(HealthDay)—Compared with placebo, saw palmetto, even at a dose as high as 960 mg, does not affect serum prostate-specific antigen (PSA) levels in men with lower urinary tract symptoms, according to research published in ...

Oncology & Cancer

Impact of 2012 USPSTF guideline against PSA screening explored

(HealthDay)—Patients undergoing prostate needle biopsies after the 2012 U.S. Preventive Services Task Force (USPSTF) recommendation against prostate-specific antigen-based screening for prostate cancer for men of any age ...

Diseases, Conditions, Syndromes

Suboptimal guideline adherence for hematuria after menopause

(HealthDay)—The prevalence of urinary tract malignancy is low among postmenopausal women evaluated for asymptomatic microscopic hematuria, according to a study published in the April issue of The Journal of Urology.

Diseases, Conditions, Syndromes

Effect of shock wave treatment for erectile dysfunction wanes

(HealthDay)—Low-intensity shock wave treatment is effective for short-term treatment of erectile dysfunction, but its efficacy declines after two years, particularly in those with initial severe dysfunction, according to ...

page 3 from 31